Hypoxia Image-Guided Radiation Therapy
缺氧影像引导放射治疗
基本信息
- 批准号:8519383
- 负责人:
- 金额:$ 41.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-01 至 2017-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Head and neck squamous cell carcinoma (HNSCC) is a debilitating and lethal disease. Despite significant advances in radiotherapy and surgical management, the 5-year survival rates have remained suboptimal. To improve therapeutic outcomes, better biomarkers and targeted therapeutic approaches are needed. Novel biomarkers can provide guidance for patient stratification and can optimize therapeutic strategy by improving patient survival and/or decreasing treatment-related toxicities. Although the recent focus on biomarkers for HNSCC has been on the human papilloma virus (HPV) status, additional efforts in improving the efficacy of individualized therapy have lead to the discovery of a number of promising epigenetic or genomic based markers as well as non-invasive functional imaging. One known cause of locoregional failure or distant metastasis after radiotherapy for HNSCC is tumor hypoxia. We propose that in tumors with positive HPV status and no hypoxia before radiotherapy or rapid resolution of tumor hypoxia (depicted by fluoromisonidazole positron emission tomography or 18F- FMISO PET) during treatment, a less intensive and less toxic regimen will yield the same tumor control as the standard 70Gy approach (intensity reduction or non- inferiority approach in Aim 1). To perform dose de-escalation in a safe manner, we propose to limit de-escalation to the node(s) of HPV+ HNSCC. All of these patients who underwent dose de-escalation to the node(s) will also undergo neck dissection as part of their treatment. On the other hand, HPV negative tumors with the presence of hypoxia before radiotherapy and with persistent hypoxia during treatment may require more aggressive therapy (intensity escalation or superiority approach). In Aim 2, we will determine using quantitative metrics between hypoxia 18F-FMISO image findings versus tumor treatment response in a HPV negative cohort. In Aim 3, we will conduct an imaging-pathological study to detail the spatial and temporal correlation between the evolution of 18F-FMISO imaging signal and change in hypoxia biomarker expression. Obtaining longitudinal profile of any given hypoxia biomarker will require repeated biopsies of tumors during a course of radiotherapy which in general has not been received well by the patient. Therefore, a priori using noninvasive 18F-FMISO PET is more appealing and practical. Confirmation of 18F-FMISO-biomarker correlation in Aim 3 will provide physicians a noninvasive avenue in selecting tumors likely to spread distantly for more intensive or novel therapy.
描述(由申请人提供):头部和颈部鳞状细胞癌(HNSCC)是一种令人衰弱的致命疾病。尽管放疗和手术治疗取得了重大进展,但5年的存活率仍然是最佳的。为了改善治疗结果,需要更好的生物标志物和靶向治疗方法。新型生物标志物可以为患者分层提供指导,并可以通过改善患者生存和/或降低与治疗相关的毒性来优化治疗策略。尽管最近对HNSCC生物标志物的重点是人类乳头状瘤病毒(HPV)状态,但在提高个性化疗法的疗效方面的额外努力导致发现了许多有希望的表观遗传学或基因组标记物以及非侵入性功能成像。 HNSCC放射疗法后,局部区域衰竭或远处转移的一个已知原因是肿瘤缺氧。我们提出,在放射疗法前呈阳性HPV状态且无缺氧或肿瘤缺氧的快速分辨率(通过荧光症甲唑唑次唑次座位发射断层扫描或18F-FMISO PET)在治疗过程中,在强度较小且毒性较低的治疗方案中会产生相同的肿瘤控制,因为标准的70GY方法将产生相同的肿瘤控制(强度下降或非次要地下性,目标是1)。为了以安全的方式执行剂量降级,我们建议将降级限制为HPV+ HNSCC的节点。所有这些接受剂量降低到节点的患者也将作为治疗的一部分进行颈部解剖。另一方面,放射治疗前缺氧和治疗期间持续性缺氧的HPV阴性肿瘤可能需要更具侵略性的治疗(强度升级或优越性方法)。在AIM 2中,我们将确定使用HPV阴性队列中缺氧18F-FMISO图像发现与肿瘤治疗反应之间的定量指标。在AIM 3中,我们将进行一项成像病理学研究,以详细说明18F-FMISO成像信号的演变与缺氧生物标志物表达的变化之间的空间和时间相关性。在放射治疗过程中,获得任何给定的低氧生物标志物的纵向轮廓将需要重复的肿瘤活检,这通常不受患者的良好接受。因此,先验使用非侵入性18F-Fmiso PET更具吸引力和实用性。 AIM 3中18F-Fmiso-Biomarker相关性的确认将为医生提供无创的途径,以选择可能远距离扩散以进行更深入或新颖的疗法的肿瘤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Nancy Y Lee其他文献
Spontaneous healing of mandibular fracture due to osteoradionecrosis
放射性骨坏死引起的下颌骨骨折自然愈合
- DOI:10.1016/j.oor.2023.10012510.1016/j.oor.2023.100125
- 发表时间:20232023
- 期刊:
- 影响因子:0
- 作者:Kevin Chung;Annu Singh;Richard Wong;Nancy Y Lee;J. Huryn;C. EstiloKevin Chung;Annu Singh;Richard Wong;Nancy Y Lee;J. Huryn;C. Estilo
- 通讯作者:C. EstiloC. Estilo
Effect of time-of-day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trial.
每日定时纳武单抗和立体定向放射治疗对转移性头颈鳞状细胞癌的影响:一项前瞻性随机试验的二次分析。
- DOI:
- 发表时间:20242024
- 期刊:
- 影响因子:0
- 作者:James R Janopaul;Lillian Boe;Yao Yu;E. Sherman;D. Pfister;Nancy Y Lee;S. McBrideJames R Janopaul;Lillian Boe;Yao Yu;E. Sherman;D. Pfister;Nancy Y Lee;S. McBride
- 通讯作者:S. McBrideS. McBride
共 2 条
- 1
Nancy Y Lee的其他基金
Dose de-escalation of HPV-associated oropharynx cancers: Exploration of HPV mediated radiation sensitivity
HPV 相关口咽癌的剂量递减:HPV 介导的辐射敏感性的探索
- 批准号:1074766310747663
- 财政年份:2020
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
使用缺氧解决方案指导治疗性辐射剂量减少至 30 Gy 的个性化方法:HPV 相关口咽癌的新型降级范例
- 批准号:1037201310372013
- 财政年份:2020
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
使用缺氧解决方案指导治疗性辐射剂量减少至 30 Gy 的个性化方法:HPV 相关口咽癌的新型降级范例
- 批准号:98877129887712
- 财政年份:2020
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
使用缺氧解决方案指导治疗性辐射剂量减少至 30 Gy 的个性化方法:HPV 相关口咽癌的新型降级范例
- 批准号:1011720510117205
- 财政年份:2020
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
A personalized approach using hypoxia resolution to guide curative-intent radiation dose reduction to 30 Gy: A novel de-escalation paradigm for HPV-associated oropharynx cancers
使用缺氧解决方案指导治疗性辐射剂量减少至 30 Gy 的个性化方法:HPV 相关口咽癌的新型降级范例
- 批准号:1057085210570852
- 财政年份:2020
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
Hypoxia Image-Guided Radiation Therapy
缺氧影像引导放射治疗
- 批准号:90688209068820
- 财政年份:2012
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
Hypoxia Image-Guided Radiation Therapy
缺氧影像引导放射治疗
- 批准号:82364988236498
- 财政年份:2012
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
Hypoxia Image-Guided Radiation Therapy
缺氧影像引导放射治疗
- 批准号:86777988677798
- 财政年份:2012
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
相似国自然基金
基因与家庭不利环境影响儿童反社会行为的表观遗传机制:一项追踪研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
不利地质结构对地下洞室群围岩地震响应影响研究
- 批准号:51009131
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
列车制动力对铁路桥梁的作用机理及最不利影响的研究
- 批准号:50178004
- 批准年份:2001
- 资助金额:23.0 万元
- 项目类别:面上项目
相似海外基金
Impacts of Acute Ambient Air Pollution Exposure on Women's Reproductive Health: Identifying Mechanisms and Susceptible Reproductive Processes Across the Menstrual Cycle and Early Pregnancy
急性环境空气污染暴露对女性生殖健康的影响:确定月经周期和怀孕早期的机制和易受影响的生殖过程
- 批准号:1064581810645818
- 财政年份:2023
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
Sensory Mechanisms of Cadmium-Induced Behavioral Disorders Across Generations
镉引起的几代人行为障碍的感觉机制
- 批准号:1074755910747559
- 财政年份:2023
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
Toxicology and Efficacy Studies of Intrathecal VersaMab-101 for spinal cord injury treatment
鞘内注射 VersaMab-101 治疗脊髓损伤的毒理学和疗效研究
- 批准号:1069726210697262
- 财政年份:2023
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
A Trauma-Informed Intervention for Sexual Minority Men Recently Diagnosed with HIV
针对最近诊断出感染艾滋病毒的性少数男性的创伤知情干预
- 批准号:1077071810770718
- 财政年份:2023
- 资助金额:$ 41.13万$ 41.13万
- 项目类别:
Fluorescence-Solid Phase Extraction (F-SPE) Platform for Rapid, On-site Detection of PFAS
用于快速现场检测 PFAS 的荧光固相萃取 (F-SPE) 平台
- 批准号:1069951410699514
- 财政年份:2023
- 资助金额:$ 41.13万$ 41.13万
- 项目类别: